Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience Acquires BioRobotics for $3.2M

NEW YORK, Sept. 22 (GenomeWeb News) - Harvard Bioscience said Friday that its Genomic Solutions subsidiary had acquired microarray instrumentation firm BioRobotics, a subsidiary of Apogent Technologies, for approximately $3.2 million in cash and certain limited liabilities.

BioRobotics sells robotics for DNA microarray manufacturing and colony picking. Jeff Williams, president of Genomic Solutions, said the Cambridge, UK-based firm's product line would complement that of GeneMachines, a company it acquired last March for $8.3 million, with "GeneMachines' strength in high-capacity arrayers and BioRobotics' strength in bench top instruments."

Williams said that BioRobotics' UK-based support and sales staff will join Genomic Solutions' UK sales and marketing team, while product development and manufacturing will be consolidated into the company's Huntingdon, UK facility.

BioRobotics is expected to achieve revenues of approximately $3 million in 2004.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.